8-KEarnings & ResultsExhibits & Filings

BIOGEN INC. 8-K Report, Financial Results (Feb 6, 2008)

Filed February 6, 2008For Securities:BIIB

Summary

Biogen Inc. (BIIB) filed an 8-K on February 6, 2008, to announce its financial results for the full year and fourth quarter ended December 31, 2007. The primary purpose of this filing is to furnish a press release containing these operational and financial performance details. Investors should note that this press release, while providing crucial financial updates, is furnished and not deemed "filed" under the Securities Exchange Act of 1934. This means it does not carry the same regulatory implications as a fully filed document but serves as a key communication channel for the company's performance. The significance of this 8-K lies in its role as the official public disclosure of Biogen's 2007 financial performance and its outlook, as communicated through the press release. Investors and analysts will look to this information to assess the company's revenue generation, profitability, and overall financial health at the close of the fiscal year and the end of the fourth quarter. The filing itself is a procedural step, with the substantive financial information contained within the accompanying press release (Exhibit 99.1).

Key Highlights

  • 1Biogen Inc. (BIIB) filed an 8-K on February 6, 2008.
  • 2The filing announces Biogen's financial results for the full year and the fourth quarter ended December 31, 2007.
  • 3The primary content is a press release (Exhibit 99.1) detailing operational results and financial condition.
  • 4This 8-K is furnished under Item 2.02, meaning the press release is provided but not formally 'filed' for purposes of Section 18 of the Exchange Act.
  • 5Investors should refer to the furnished press release (Exhibit 99.1) for the specific financial and operational data.
  • 6The filing serves as the official communication of Biogen's year-end 2007 financial performance.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially announce and provide Biogen Inc.'s financial results for the full year and the fourth quarter ended December 31, 2007, through a furnished press release.

The specific financial and operational results are detailed in the press release dated February 6, 2008, which is included as Exhibit 99.1 to this 8-K filing.

No, the press release is furnished under Item 2.02 and is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. This means it does not subject Biogen to the liabilities associated with Section 18, nor is it automatically incorporated into other filings unless explicitly stated.

It means the company is providing the information as required for public disclosure of financial results, but it is not being submitted in a way that triggers the full legal implications of a formal filing under certain sections of securities laws. Investors should still consider the information material for their investment decisions.